US Broker Ratings

Arrowhead Pharmaceuticals (ARWR): Analyzing the Biotech Firm’s 20% Upside Potential Amidst Analyst Consensus

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands as a significant player in the biotechnology sector, focusing on developing innovative medicines for intractable diseases. With a market capitalization of $12.05 billion, this..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Exploring the Potential of a $8.72 Billion Biotech Innovator

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a prominent player in the biotechnology sector, is making waves with its promising pipeline of therapeutic candidates. With a market capitalization of $8.72 billion, this..

Surgery Partners, Inc. (SGRY) Stock Analysis: Unveiling a 22.85% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.98 billion, the company stands as..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 111% Upside in the Biosimilar Market

Investors looking for opportunities in the healthcare sector may find Alvotech (NASDAQ: ALVO) an intriguing prospect. Specializing in the development and manufacturing of biosimilar medicines, Alvotech is positioned at the..

Zai Lab Limited (ZLAB) Stock Analysis: A Compelling 78.67% Potential Upside in Biotech Innovation

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, offers a promising investment opportunity with a remarkable potential upside of 78.67%, according to analyst ratings. Despite the..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A 29% Upside Potential Amidst Promising Neurological Treatments

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a pioneering biopharmaceutical company in the healthcare sector, is making waves with its focus on neurological and rare diseases. With a market capitalization of $4.35..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A Healthcare Giant with 25.6% Revenue Growth and Strong Buy Ratings

BrightSpring Health Services, Inc. (BTSG), a leader in the healthcare sector, particularly in health information services, has demonstrated a robust performance trajectory that has caught the attention of investors and..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a Biotech Trailblazer with a 17% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has been making waves in the biotechnology sector, offering promising therapeutic solutions for central nervous system (CNS) disorders. With a significant market cap of $12.4..

TransMedics Group, Inc. (TMDX)

⚠️ No article content returned.

..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC) is a dominant player in the healthcare sector, specializing in medical distribution. With a market cap of $9.74 billion, the company provides essential healthcare products..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Insights into a Biotech Powerhouse with a Compelling 42% Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotech sector with its innovative approaches to drug delivery and its robust financial performance. With a market capitalization of $9.72..

Ionis Pharmaceuticals (IONS) Stock Analysis: Uncovering a Potential 62% Upside in the Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands as a notable player in the biotechnology sector, attracting investor attention with its innovative RNA-targeted medicines and collaborations with major pharmaceutical entities. With a..

Prestige Consumer Healthcare (PBH) Stock Analysis: Uncovering a 34.51% Potential Upside

Prestige Consumer Healthcare Inc. (NASDAQ: PBH) stands as a notable player in the healthcare sector, specializing in the development and distribution of over-the-counter health and personal care products. With a..

Alkermes plc (ALKS) Stock Analysis: Robust Revenue Growth Amidst Strategic Expansion

Alkermes plc (NASDAQ: ALKS), an innovative player in the healthcare sector, is making significant strides in the drug manufacturing industry, particularly in specialty and generic drugs. With its headquarters in..

RadNet, Inc. (RDNT) Stock Analysis: A 45.77% Upside Potential in the Booming Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT), a leading player in the Healthcare sector, particularly within Diagnostics & Research, is attracting significant investor interest with an impressive market cap of $4.84 billion. Known..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 62% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a pioneer in the healthcare sector, continues to capture investor interest with its innovative approach to cardiac monitoring. Headquartered in San Francisco, California, iRhythm specializes..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7.17% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a notable player in the healthcare sector, has been capturing investor attention with its strong position in the drug manufacturing industry, specifically in specialty and..

Ascendis Pharma A/S (ASND) Stock Analysis: Strong Buy Ratings Signal a Promising 20.23% Upside

Ascendis Pharma A/S (NASDAQ: ASND) is gaining momentum in the biotechnology sector, capturing the attention of investors with its innovative approach to addressing unmet medical needs. Based in Hellerup, Denmark,..

Baxter International Inc. (BAX) Stock Analysis: Navigating a Healthcare Giant’s Challenges and Opportunities

Baxter International Inc. (NYSE: BAX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $11.57 billion, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds